page_title: Chemoprotective agent
hierarchical_section_title: Chemoprotective agent
context_page_description: A chemo-protective agent is any drug that helps to reduce the side- effects of chemotherapy. These agents protect specific body parts from the harmful anti-cancer treatments that could potentially cause permanent damage to important bodily tissues. Chemo-protective agents have only recently been introduced as a factor involved with chemotherapy with the intent to assist those cancer patients that require treatment, which as an end result, improves the patients' quality of life. There have been a few studies on these agents though most of them come to the same conclusion, so what is known about them isn't very broad. Information including examples, risks, and more are the most researched aspects of Chemo protective agents.
  Examples include:
  Amifostine, approved by the FDA in 1995, which helps prevent kidney damage in patients undergoing cisplatin and carboplatin chemotherapy
  Mesna, approved by the FDA in 1988, which helps prevent hemorrhagic cystitis in patients undergoing cyclophosphamide or ifosfamide chemotherapy
  Dexrazoxane, approved by the FDA in 1995, which helps prevent heart problems in patients undergoing doxorubicin chemotherapy
context_section_description: A chemo-protective agent is any drug that helps to reduce the side- effects of chemotherapy. These agents protect specific body parts from the harmful anti-cancer treatments that could potentially cause permanent damage to important bodily tissues. Chemo-protective agents have only recently been introduced as a factor involved with chemotherapy with the intent to assist those cancer patients that require treatment, which as an end result, improves the patients' quality of life. There have been a few studies on these agents though most of them come to the same conclusion, so what is known about them isn't very broad. Information including examples, risks, and more are the most researched aspects of Chemo protective agents. 
  Examples include: 
  Amifostine, approved by the FDA in 1995, which helps prevent kidney damage in patients undergoing cisplatin and carboplatin chemotherapy
  Mesna, approved by the FDA in 1988, which helps prevent hemorrhagic cystitis (bladder bleeding) in patients undergoing cyclophosphamide or ifosfamide chemotherapy
  Dexrazoxane, approved by the FDA in 1995, which helps prevent heart problems in patients undergoing doxorubicin chemotherapy
caption: Amifostine; A common chemo-protective agent that has been approved by the FDA.